Logo (How Supplied Logo)
Bacteriostatic Water Injection, Solution
Product Images NDC 51662-1473
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bacteriostatic Water (NDC 51662-1473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
How Supplied (How Supplied)
The text describes two different products that contain benzyl alcohol as a preservative. The first product has an NDC (National Drug Code) number of 0409-3977-03, comes in a tray of 25, and has a concentration of 9 mg/mL. The product is packaged in multiple-dose 30 mL plastic Fliptop vials. The second product has an NDC number of 0409-1093-04, comes in a tray of 25, and has a concentration of 11 mg/mL. The product is packaged in multiple-dose 20 mL fill in 30 mL glass Fliptop vials.*
Serialized Vial Labeling (Seerialized Labeling)
This is a description of a 30 mL multiple-dose medication that is distributed by HF Acquisition Co., LLC. The lot number of the medication is 03-233-0KE. The manufacturer's package should be consulted before use. The medication is not suitable for neonates. Otherwise, there is not enough readable text to provide additional detail.*
Spl (Spl Unclassified)
This is a warning message indicating that the product should NOT be used in neonates (newborn babies up to 28 days old).*
Principal Display Panel (VIAL LABEL OPTION 1)
This is a description of a pharmaceutical product in the form of a 30 ML multi-dose vial with 0.9% benzyl alcohol added as a drug diluent. It is sterile, and not pyrogenic, and should not be used on neonates. The product should only be used if the cap and seal are undamaged and intact, and the stopper should be cleansed with an antiseptic solution before use. The NDC (National Drug Code) is 0409-3977-01. The company producing it is Hosgir Inc, located in Laka Forast IL, 00810 USA.*
Principal Display Panel (VIAL LABEL OPTION 2)
This is a drug diluent that should only be used with clear and unbroken packaging. It contains 0.9% benzyl alcohol and is sterile and nonpyrogenic. This product is not intended for use in neonates. The package contains a Hospira Cleanse stopper and is distributed by Hospira Inc in the USA. The product is a 30 mL multi-dose vial with the National Drug Code 0409-3977-01 and M.L. No. 08/VP/AP/2013/F/G, and PAA130068.*
Principal Display Panel (VIAL LABEL OPTION 3)
This is a description of a drug diluent with the NDC code 0409-3977-01. It comes in a 30 mL multiple-dose bottle and is not recommended for neonates. The stopper needs to be cleansed before use. The label includes a 2D barcode for tracking and human-readable information such as GTIN, SNo, Lot, and expiry. The product is manufactured by Hospira and is meant for hospital use only.*
Principal Display Panel (VIAL LABEL OPTION 4)
This is a 30mL multi-dose solution of 0.9% benzyl alcohol, which is sterile and non-pyrogenic. It is intended for use as a drug diluent and should only be used if the solution is clear, and the seal is intact and undamaged. It is recommended to clean the stopper with an antiseptic before use. This solution is not suitable for use in neonates. The product is distributed by Hospira, Inc. based in Illinois, USA.*
Principal Display Panel (VIAL LABEL OPTION 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
